Comparison between Infinium Pharmachem IPO and Pattech Fitwell Tube IPO.
Infinium Pharmachem IPO is a SME Fixed Price IPO proposed to list at NSE SME while Pattech Fitwell Tube IPO is a SME Fixed Price proposed to list at NSE SME.
| Infinium Pharmachem IPO | Pattech Fitwell Tube IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Fedex Securities Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Swastika Investmart Ltd. | Pure Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Infinium Pharmachem IPO is up to ₹23.99 Cr whereas the issue size of the Pattech Fitwell Tube IPO is up to ₹11.37 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Pattech Fitwell Tube IPO is ₹50.00 per share.
| Infinium Pharmachem IPO | Pattech Fitwell Tube IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹135.00 per share | ₹50.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹13.50 per share | |
| Market Lot Size | 1000 shares | 3000 shares |
| Fresh Issue Size | 17,81,000 shares | 22,74,000 shares |
| Fresh Issue Size (Amount) | up to ₹23.99 Cr | up to ₹11.37 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,81,000 shares | 22,74,000 shares |
| Issue Size Total (Amount) | up to ₹23.99 Cr | up to ₹11.37 Cr |
Infinium Pharmachem IPO opens on Mar 31, 2023, while Pattech Fitwell Tube IPO opens on Apr 05, 2023. The closing date of Infinium Pharmachem IPO and Pattech Fitwell Tube IPO is Apr 05, 2023, and Apr 12, 2023, respectively.
| Infinium Pharmachem IPO | Pattech Fitwell Tube IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 31, 2023 | Apr 05, 2023 |
| Issue Close | Apr 05, 2023 | Apr 12, 2023 |
| Basis Of Allotment (Tentative) | Apr 11, 2023 | Apr 18, 2023 |
| Initiation of Refunds (Tentative) | Apr 12, 2023 | Apr 19, 2023 |
| Credit of Share (Tentative) | Apr 13, 2023 | Apr 20, 2023 |
| Listing date (Tentative) | Apr 17, 2023 | Apr 21, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Pattech Fitwell Tube IPO P/E ratio of 46.73.
| Infinium Pharmachem IPO | Pattech Fitwell Tube IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.05 | 69.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 7.83 | 46.73 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.93 Cr. | ₹38.79 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.85 | 25.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 72 | 11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹54.13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 46.61 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Infinium Pharmachem IPO Retail Individual Investors (RII) are offered 8,70,000 shares while in Pattech Fitwell Tube IPO retail investors are offered 8,70,000 shares. Qualified Institutional Buyers (QIB) are offered in Infinium Pharmachem IPO and in Pattech Fitwell Tube IPO.
| Infinium Pharmachem IPO | Pattech Fitwell Tube IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 94,000 shares | 1,26,000 shares |
| QIB | ||
| NII | 8,70,000 shares | 11,37,000 shares |
| RII | 8,70,000 shares | 11,37,000 shares |
| Employee | 41,000 shares | |
| Others | ||
| Total | 17,81,000 shares | 22,74,000 shares |
Infinium Pharmachem IPO subscribed 1.92x in total, whereas Pattech Fitwell Tube IPO subscribed 1.97x.
| Infinium Pharmachem IPO | Pattech Fitwell Tube IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.94x | 2.05x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.00x | 1.90x |
| Employee (times) | 1.29x | |
| Other (times) | ||
| Total (times) | 1.92x | 1.97x |
